ALBENDAZOLE
- Product NDC
- 69097-237
- 11-digit product format
- 690970237
- Labeler code
- 69097
- Product ID
- 69097-237_f1655e51-6ba7-4a47-8acf-cbbf44e10db5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- albendazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA210434
- Marketing category
- ANDA
- Marketing start
- 2018-09-24
- Marketing end
- 0000-00-00
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-237 | ALBENDAZOLE TABLET [CIPLA USA INC.] | 5 | Legacy NDC | 20221206_0a4ce2e1-db3d-4b24-98aa-0519fbaff547.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-237-72 | 69097023772 | 2 TABLET in 1 BOTTLE (69097-237-72) | 2 tablet | 2018-09-24 | 0000-00-00 | No | No | Current |
| 69097-237-73 | 69097023773 | 28 TABLET in 1 BOTTLE (69097-237-73) | 28 tablet | 2018-09-24 | 0000-00-00 | No | No | Current |